Welcome to our dedicated page for BALYT news (Ticker: BALYT), a resource for investors and traders seeking the latest updates and insights on BALYT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BALYT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BALYT's position in the market.
Bally's (NYSE: BALY) has completed its merger with The Queen Casino & Entertainment, resulting in Queen shareholders receiving 30.5 million shares. The company paid cash consideration of $18.25 per share to holders of 22.8 million outstanding shares, financed through $500 million in senior secured notes and available funds.
Following the transaction, 17.9 million shareholders retained their stock through rollover election, bringing the total outstanding shares to 48.4 million. Additionally, warrants for 11.6 million shares remain outstanding. The company now operates 19 casinos across 11 U.S. states, including a golf course in New York and a horse racetrack in Colorado.
Two properties, Belle of Baton Rouge and Casino Queen Marquette, are undergoing land-side conversions expected to complete in 2025. Bally's maintains online sports betting licenses in 13 North American jurisdictions and operates Bally Bet and Bally Casino platforms.
Bally's (NYSE: BALY) has completed its second election period for shareholders to keep their shares outstanding following the planned merger with Casino Queen. An additional 447,910 shares were elected in this period, bringing the total to 17,940,083 shares of common stock and warrants for 11,191,061 shares that will remain outstanding after the merger.
Upon completion of the merger, approximately 30.5 million shares will be issued to Casino Queen stockholders and warrant holders, resulting in about 48.4 million total pro forma shares outstanding, plus warrants for approximately 11.6 million shares. Shares under Rolling Share Elections will trade as 'BALY.T' until the merger's completion, when they will revert to 'BALY'. The transaction is expected to close in Q1 2025, subject to regulatory approvals.
Bally's (NYSE: BALY) has completed the sale lease-back of real property interests for Bally's Kansas City and Bally's Shreveport to Gaming and Leisure Properties (GLPI) in a transaction valued at $395 million. The deal includes $7 million in LP units and $388 million in cash, with $56 million reimbursement for prior capital expenditures.
The proceeds will be used to reduce the company's $620 million revolving credit facility (of which $350 million was drawn as of September 30, 2024) and fund capital expenditures. The properties have been added to a new Master Lease with an initial annual cash rent of $32.2 million, including customary escalators.
Bally's (NYSE: BALY) has announced a new election period for stockholders to choose between receiving $18.25 per share cash merger consideration or keeping their shares outstanding following the merger transaction approval. The new election period runs from December 11, 2024, to January 17, 2025. Stockholders who elect to keep their shares will receive new CUSIP-numbered shares tradeable on NYSE under BALY.T. As of November 19, 2024, approximately 17.5 million shares had already elected to roll over, including 8.8 million shares from Standard General L.P. and affiliates. The merger closing is expected in Q1 2025, subject to regulatory approvals.
